The overall objective of this proposal is to elucidate the cellular, biochemical and molecular mechanisms involved in modulation of T-cell function by catecholamines. Studies are designed to investigate the immunologic consequences of stimulating the beta 2 adrenergic receptor (BAR) on T-cells and their subsets with triggering through the T-cell receptor (TCR). This dual signaling will be achieved by stimulating resting human T-cells with the beta adrenergic agonist isoproterenol (ISO) and the mitogen anti-T3 monoclonal antibody (mab) or phytohemagglutinin (PHA). The experiments are proposed to determine the temporal immunomodulatory effect of this dual receptor interaction on transit of T-cells through the cell cycle from G(O) - G(l) and from G(1) - S phase as reflected by cell cycle analyses, interleukin 2 (IL-2) production and expression of the IL-2 receptor (IL-2R). Because T-cells also require signals from accessory cells to become fully activated, the effects of BAR stimulation on monocytes will be determined. These experiments including assessing the effects of ISO on the ability of monocytes to produce cytokines and express """"""""Ia"""""""" antigen. A further delineation of the characteristics of the synergistic rise in cAMP levels in T-cells after stimulation with ISO and anti-T3 mAb or PHA are proposed. Experiments are presented to identify those elements of the cAMP second messenger system which are modulated via dual stimulation of the BAR and TCR. These include modulation of the BAR, G-proteins, adenylate cyclase and cAMP phosphodiesterase activity. Concurrently, we also will examine how second messengers (Ca2+, protein kinase C) emanating from TCR stimulation are capable of facilitating cAMP accumulation in T-cells. The final set of experiments will determine the effects of dual receptor interactions on a variety of transmembrane signals resulting from phosphotidylinositol cycle turnover and oncogene expression associated with the ability of appropriately stimulated T-cells to enter and transit the cell cycle from G(O) - G(1). Experiments also are presented to evaluate those intracellular events linked with continued progression from G(1) to the S phase of the proliferative cycle.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS017423-10
Application #
3397574
Study Section
Neurology C Study Section (NEUC)
Project Start
1981-09-01
Project End
1995-06-30
Budget Start
1991-07-01
Budget End
1992-06-30
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Rock, M T; Brooks, W H; Roszman, T L (1997) Calcium-dependent signaling pathways in T cells. Potential role of calpain, protein tyrosine phosphatase 1b, and p130Cas in integrin-mediated signaling events. J Biol Chem 272:33377-83
Elliott, L H; Levay, A K; Sparks, B et al. (1996) Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a cAMP-independent mechanism. Cell Immunol 169:117-24
Selliah, N; Bartik, M M; Carlson, S L et al. (1995) cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization. J Neuroimmunol 56:107-12
Bauman, G P; Bartik, M M; Brooks, W H et al. (1994) Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 158:182-94
Carlson, S L; Trauth, K; Brooks, W H et al. (1994) Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells. J Cell Physiol 161:39-48
Bartik, M M; Bauman, G P; Brooks, W H et al. (1994) Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol 158:116-30
Elliott, L; Brooks, W; Roszman, T (1993) Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2. Cell Mol Neurobiol 13:579-92
Bartik, M M; Brooks, W H; Roszman, T L (1993) Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation. Cell Immunol 148:408-21
Elliott, L; Brooks, W; Roszman, T (1992) Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 12:411-27
Roszman, T L; Brooks, W H (1992) Signaling pathways of the neuroendocrine-immune network. Chem Immunol 52:170-90

Showing the most recent 10 out of 22 publications